Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Accipiolx

K-Number: K201310 · 2020-08-07

Decision Date2020-08-07
Product CodeQAS
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Accipiolx is a medical device manufactured by Maxq AL , Ltd.. It received FDA 510(k) clearance on 2020-08-07 under approval number K201310. The device is classified under product code QAS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Accipiolx?

Accipiolx is a medical device that received FDA 510(k) clearance on 2020-08-07. It is manufactured by Maxq AL , Ltd.. The 510(k) number is K201310.

When was Accipiolx approved by the FDA?

Accipiolx received FDA 510(k) clearance on 2020-08-07, under approval number K201310.

What company makes Accipiolx?

Accipiolx is manufactured by Maxq AL , Ltd..

What is the FDA product code for Accipiolx?

The FDA product code for Accipiolx is QAS.

Related Devices (Code: QAS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.